Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate

Abstract Chronic myelomonocytic leukemia (CMML) is an entity of myelodysplastic syndrome/myeloproliferative neoplasm. Although CMML can be cured with allogeneic stem cell transplantation, its prognosis is generally very poor due to the limited efficacy of chemotherapy and to the patient’s age, which...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Kazuki Taoka, Shunya Arai, Keisuke Kataoka, Masataka Hosoi, Masashi Miyauchi, Sho Yamazaki, Akira Honda, Wei Aixinjueluo, Takashi Kobayashi, Keiki Kumano, Akihide Yoshimi, Makoto Otsu, Akira Niwa, Tatsutoshi Nakahata, Hiromitsu Nakauchi, Mineo Kurokawa
Format:	article
Langue:	EN
Publié:	Nature Portfolio 2018
Sujets:	Chronic Myelomonocytic Leukemia (CMML) Clodronate Liposomes Drug Testing Systems Teratoma Hematopoietic Progenitor Cells (HPCs) Medicine R Science Q
Accès en ligne:	https://doaj.org/article/ca6c14c5e42546afa52dabe821a5a19d
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Soyez le premier à ajouter un commentaire!

Using patient-derived iPSCs to develop humanized mouse models for chronic myelomonocytic leukemia and therapeutic drug identification, including liposomal clodronate

Documents similaires